Patents by Inventor Juan Francisco Caturla Javaloyes

Juan Francisco Caturla Javaloyes has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOUNDS ACTIVE TOWARDS NUCLEAR RECEPTORS
    Publication number: 20230271937
    Abstract: Disclosed are compounds active towards nuclear receptors, pharmaceutical compositions containing the compounds and use of the compounds in therapy.
    Type: Application
    Filed: May 5, 2023
    Publication date: August 31, 2023
    Inventors: Sanne Schrøder Glad, Ian Sarvary, Alex Haahr Gouliaev, Thomas Franch, Søren Jensby Nielsen, Luigi Piero Stasi, Montserrat Erra Solà, Lorena Taboada Martínez, Joan Taltavull Moll, Juan Francisco Caturla Javaloyes, Lluís Miquel Pagès Santacana
  • Compounds active towards nuclear receptors
    Patent number: 11685727
    Abstract: Disclosed are compounds active towards nuclear receptors, pharmaceutical compositions containing the compounds and use of the compounds in therapy.
    Type: Grant
    Filed: December 18, 2020
    Date of Patent: June 27, 2023
    Assignee: NUEVOLUTION A/S
    Inventors: Sanne Schrøder Glad, Ian Sarvary, Alex Haahr Gouliaev, Thomas Franch, Søren Jensby Nielsen, Luigi Piero Stasi, Montserrat Erra Solà, Lorena Taboada Martínez, Joan Taltavull Moll, Juan Francisco Caturla Javaloyes, Lluís Miquel Pagès Santacana
  • COMPOUNDS ACTIVE TOWARDS NUCLEAR RECEPTORS
    Publication number: 20210188807
    Abstract: Disclosed are compounds active towards nuclear receptors, pharmaceutical compositions containing the compounds and use of the compounds in therapy.
    Type: Application
    Filed: December 18, 2020
    Publication date: June 24, 2021
    Inventors: Sanne Schrøder Glad, Ian Sarvary, Alex Haahr Gouliaev, Thomas Franch, Søren Jensby Nielsen, Luigi Piero Stasi, Montserrat Erra Solà, Lorena Taboada Martínez, Joan Taltavull Moll, Juan Francisco Caturla Javaloyes, Lluís Miquel Pagès Santacana
  • Cyclohexylamine derivatives having ?2 adrenergic antagonist and M3 muscarinic antagonist activities
    Patent number: 9643961
    Abstract: The present invention relates to novel compounds having ?2 adrenergic agonist and M3 muscarinic antagonist dual activity, to pharmaceutical compositions containing them, to the process for their preparation and to their use in respiratory therapies.
    Type: Grant
    Filed: March 14, 2016
    Date of Patent: May 9, 2017
    Assignee: Almirall, S.A.
    Inventors: Maria Prat Quinones, Silvia Fonquerna Pou, Carlos Puig Duran, Wenceslao Lumeras Amador, Jose Aiguade Bosch, Juan Francisco Caturla Javaloyes
  • NEW CYCLOHEXYLAMINE DERIVATIVES HAVING ß2 ADRENERGIC AGONIST AND M3 MUSCARINIC ANTAGONIST ACTIVITIES
    Publication number: 20160264557
    Abstract: The present invention relates to novel compounds having ?2 adrenergic agonist and M3 muscarinic antagonist dual activity, to pharmaceutical compositions containing them, to the process for their preparation and to their use in respiratory therapies.
    Type: Application
    Filed: March 14, 2016
    Publication date: September 15, 2016
    Inventors: Maria PRAT QUINONES, Silvia FONQUERNA POU, Carlos PUIG DURAN, Wenceslao LUMERAS AMADOR, Jose AIGUADE BOSCH, Juan Francisco CATURLA JAVALOYES
  • Pyrrolotriazinone derivatives as PI3K inhibitors
    Patent number: 9388189
    Abstract: New pyrrolotriazinone derivatives having the chemical structure of Formula (I) are disclosed; as well as process for theft preparation, pharmaceutical compositions comprising them and their use in therapy as inhibitors of Phosphoinositide 3-Kinases (PI3Ks).
    Type: Grant
    Filed: October 15, 2013
    Date of Patent: July 12, 2016
    Assignee: Almirall, S.A.
    Inventors: Montserrat Erra Sola, Marta Carrascal Riera, Joan Taltavull Moll, Juan Francisco Caturla Javaloyes, Francisco Javier Bernal Anchuela, Lluis Miquel Pages Santacana, Marta Mir Cepeda, Gaspar Casals Coll, Maria Begoña Hernandez Olasagarre
  • Pyrrolotriazinone derivatives as inhibitors P13K
    Patent number: 9340547
    Abstract: New pyrrolotriazinone derivatives having the chemical structure of formula (I) are disclosed; as well as process for their preparation, pharmaceutical compositions comprising them and their use in therapy as inhibitors of Phosphoinositide 3-Kinases (PI3Ks).
    Type: Grant
    Filed: April 26, 2012
    Date of Patent: May 17, 2016
    Assignee: Almirall, S.A.
    Inventors: Francisco Javier Bernal Anchuela, Marta Carrascal Riera, Juan Francisco Caturla Javaloyes, Jordi Gracia Ferrer, Victor Giulio Matassa, Emma Terricabras Belart, Joan Taltavull Moll, Montserrat Erra Sola
  • PYRROLOTRIAZINONE DERIVATIVES AS PI3K INHIBITORS
    Publication number: 20150291595
    Abstract: New pyrrolotriazinone derivatives having the chemical structure of Formula (I) are disclosed; as well as process for theft preparation, pharmaceutical compositions comprising them and their use in therapy as inhibitors of Phosphoinositide 3-Kinases (PI3Ks).
    Type: Application
    Filed: October 15, 2013
    Publication date: October 15, 2015
    Inventors: Montserrat Erra Sola, Marta Carrascal Riera, Joan Taltavull Moll, Juan Francisco Caturla Javaloyes, Francisco Javier Bernal Anchuela, Lluis Miquel Pages Santacana, Marta Mir Cepeda, Gaspar Casals Coll, Maria Begoña Hernandez Olasagarre
  • PYRROLOTRIAZINONE DERIVATIVES AS PI3K INHIBITORS
    Publication number: 20150099752
    Abstract: New pyrrolotriazinone derivatives having the chemical structure of formula (I) are disclosed; as well as process for their preparation, pharmaceutical compositions comprising them and their use in therapy as inhibitors of Phosphoinositide 3-Kinases (PI3Ks).
    Type: Application
    Filed: April 26, 2012
    Publication date: April 9, 2015
    Applicant: ALMIRALL, SA
    Inventors: Francisco Javier Bernal Anchuela, Marta Carrascal Riera, Juan Francisco Caturla Javaloyes, Jordi Gracia Ferrer, Victor Giulio Matassa, Emma Terricabras Belart, Joan Tal Tavul Moll, Montserat Eraa Sola
  • PYRROLOTRIAZINONE DERIVATIVES AS P13K INHIBITORS
    Publication number: 20140163033
    Abstract: New pyrrolotriazinone derivatives having the chemical structure of formula (I) are disclosed; as well as process for their preparation, pharmaceutical compositions comprising them and their use in therapy as inhibitors of Phosphoinositide 3-Kinases (PI3Ks).
    Type: Application
    Filed: April 26, 2012
    Publication date: June 12, 2014
    Applicant: ALMIRALL, SA
    Inventors: Francisco Javier Bernal Anchuela, Marta Carrascal Riera, Juan Francisco Caturla Javaloyes, Jordi Gracia Ferrer, Victor Giulio Matassa, Emma Terricabras Belart, Joan Tal Tavul Moll, Montserat Eraa Sola
  • NEW CYCLOHEXYLAMINE DERIVATIVES HAVING ß2 ADRENERGIC AGONIST AND M3 MUSCARINIC ANTAGONIST ACTIVITIES
    Publication number: 20130281415
    Abstract: The present disclosure relates to novel compounds having ?2 adrenergic agonist and M3 muscarinic antagonist dual activity, to pharmaceutical compositions containing them, to the process for their preparation and to their use in respiratory therapies.
    Type: Application
    Filed: May 13, 2011
    Publication date: October 24, 2013
    Inventors: Maria Prat Quinones, Silvia Fonquerna Pou, Carlos Puig Duran, Wenceslao Lumeras Amador, Jose Aiguade Bosch, Juan Francisco Caturla Javaloyes
  • IMIDAZOPYRIDINE DERIVATIVES AS JAK INHIBITORS
    Publication number: 20130216498
    Abstract: New imidazopyridine derivatives having the chemical structure of formula (I) are disclosed; as well as process for their preparation, pharmaceutical compositions comprising them and their use in therapy as inhibitors of Janus Kinases (JAK).
    Type: Application
    Filed: December 23, 2010
    Publication date: August 22, 2013
    Inventors: Paul Robert Eastwood, Jacob Gonzales Rodriguez, Jordi Bach Taña, Lluis Miquel Pages Santacana, Joan Taltavull Moll, Juan Francisco Caturla Javaloyes, Victor Giulio Matassa
  • New Pyridin-3-Amine Derivatives
    Publication number: 20110098298
    Abstract: This invention is directed to new inhibitors of the p38 mitogen-activated protein kinase having the general formula (I) to processes for their preparation; to pharmaceutical compositions comprising them; and to their use in therapy.
    Type: Application
    Filed: February 12, 2007
    Publication date: April 28, 2011
    Inventors: Bernat Vidal Juan, Juan Francisco Caturla Javaloyes, Wenceslao Lumeras Amador, Laura Vidal Gispert
  • 1,7-naphthyridine derivatives as p38 MAP kinase inhibitors
    Patent number: 7906530
    Abstract: New inhibitors of the p38 mitogen-activated protein kinase having the general formula (I) are disclosed, as well as processes for their preparation, pharmaceutical compositions comprising them, and their use in therapy.
    Type: Grant
    Filed: August 7, 2007
    Date of Patent: March 15, 2011
    Assignee: Laboratorios Almirall, S.A.
    Inventors: Juan Francisco Caturla Javaloyes, Laura Vidal Gispert, Wenceslao Lumeras Amador
  • 1,7-NAPHTHYRIDINE DERIVATIVES AS P38 MAP KINASE INHIBITORS
    Publication number: 20100227881
    Abstract: New inhibitors of the p38 mitogen-activated protein kinase having the general formula (I) are disclosed, as well as processes for their preparation, pharmaceutical compositions comprising them, and their use in therapy.
    Type: Application
    Filed: August 7, 2007
    Publication date: September 9, 2010
    Inventors: Juan Francisco Caturla Javaloyes, Laura Vidal Gispert, Wenceslao Lumeras AMADOR
  • 2-phenylpyran-4-one derivatives as selective COX-2 inhibitors
    Patent number: 7582676
    Abstract: The present invention relates to 2-phenylpyran-4-derivatives of general formula (I), processes for their preparation, pharmaceutical compositions containing them, and their medical uses.
    Type: Grant
    Filed: February 12, 2004
    Date of Patent: September 1, 2009
    Assignee: Laboratorios Almirall, S.A.
    Inventors: Juan Francisco Caturla Javaloyes, Graham Warrellow